Use of Botulinum Toxin in the Treatment of Achalasia

Digestive Diseases

Volumn 16, Issue 1, 1998, Pages 14-22

  Schiano, Thomas D ^a   Parkman, Henry P ^a   Miller, Larry S ^a   Dabezies, Marta A ^a   Cohen, Sidney ^a   Fisher, Robert S ^a  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Achalasia; Botulinum toxin; Esophageal motility disorders

Indexed keywords

ANTIPARKINSON AGENT; BOTULINUM TOXIN;

ESOPHAGUS ACHALASIA; HUMAN; REVIEW;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; ESOPHAGEAL ACHALASIA; HUMANS;

EID: 0031612067     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016845     Document Type: Review

References (50)

1. Reynolds JC, Parkman HP: Achalasia. Gastroenterol Clin North Am 1989;18:223-255.
2. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN: Treatment of achalasia with intrasphincteric injection of botulinum toxin: A pilot trial. Ann Intern Med 1994;121: 590-591.
3. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN: Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995;322:774-778.
4. Cohen S, Lipshutz W: Lower esophageal sphincter dysfunction in achalasia. Gastroenterology 1971;61:814-821.
5. Vantrappen G, Janssens J, Hellemans J, et al: Achalasia, diffuse esophageal spasm, and related motility disorders. Gastroenterology 1979; 76:450-461.
6. Cohen S, Parkman HP: Treatment of achalasia: From whalebone to botulinum toxin. N Engl J Med 1995;332:815-816.
7. Holloway RH, Dodds WJ, Helm JF, et al: Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology 1986;90:924-929.
8. Cohen S, Fisher R, Tuch A: The site of denervation in achalasia. Gut 1972;13:556-558.
9. Vantrappen G, Hellemans J: Treatment of achalasia and related motor disorders Gastroenterology 1983;79:144-154.
10. Cox J, Buckton GK, Bennett JR: Balloon dilatation in achalasia: A new dilator. Gut 1986;27: 986-989.
11. Kadakia SC, Wong RKH: Graded pneumatic dilation using Rigiflex achalasia dilators in patients with primary esophageal achalasia. Am J Gastroenterol 1993;88:34-38.
12. Nair LA, Parkman HP, Reynolds JC, Rosato EF, Ouyang A, Strom B, Cohen S: Complications of pneumatic dilatation: Analysis of risk factors, identifying factors and outcome. Dig Dis Sci 1993;38:1893-1904.
13. Parkman HP, Reynolds JC, Ouyang A, Rosato EF, Eisenberg JM, Cohen S: Pneumatic dilatation or esophagomyotomy treatment for idiopathic achalasia: Clinical outcomes and cost analysis. Dig Dis Sci 1993;38:75-85.
14. Csendes A, Velasco N, Braghetto I, et al: A prospective randomized study comparing forceful dilatation and esophagomyotomy in patients with achalasia of the esophagus. Gastroenterology 1981;80:789-799.
15. Okike N, Payne WS, Neufielu DM, et al: Esophagomyotomy versus forceful dilation for achalasia of the esophagus. Results in 899 patients. Ann Thorac Surg 1979;28:119-130.
16. Shimi S, Nathanson LK, Cuschieri A: Laparoscopic cardiomyotomy for achalasia. J R Coll Surg Edin 1991;36:152-154.
17. Little AG, Soriano A, Ferguson MK, et al: Surgical treatment of achalasia: Results with esophagomyotomy and Belsey repair. Ann Thorac Surg 1988;45:489-499.
18. Jankovic J, Brin MF: Therapeutic uses of botuhnum toxin. N Engl J Med 1991;324:1186-1194.
19. Simpson LL: The origin, structure, and pharmacologic activity of botulinum toxin. Pharmacol Rev 1981;33.155-188.
20. Kao I, Drachman DB, Price DL: Botuiinum toxin: Mechanism of presynaptic blockade. Science 1976;193:1256-1258.
21. American Academy of Ophthalmology: Botulinum treatment of strabismus in children. Ophthalmology 1989;96:37-41.
22. Helvestone EM, Pogrebriak AE: Treatment of acquired nystagmus with botulinum A toxin. Am J Ophthalmol 1988;106:584-586.
23. Scott AB, Kennedy EG, Stubbs HA: Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol 1985;103:347-350.
24. Dutton DA, Buckley EG: Long-term results and complications of hotulinum A toxin in the treatment of blepharospasm. Ophthalmology 1988;95:1529-1534.
25. Greene P, Kang U, Fahn S, Brin MF, Moskowitz C, Plaster E: Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology 1990;40:1213-1218.
26. Brin MF, Blitzer A, Fahn S, Gould W, Lovelace RE: Adductor laryngeal dystonia (spastic dysphonia): Treatment with local injections of botulinum toxin (Botox). Mov Dis 1989;4:287-296.
27. Rivest J, Lees AJ, Marsden CD: Writer's cramp: Treatment with botulinum toxin injections. Mov Disord 1990;6:55-59.
28. Brin MF, Fahn S, Moskowitz C, et al: Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord 1987;2:237-254.
29. Tolosa E, Marti MJ, Kulisevsky J: Botulinum toxiu injection therapy for hemifacial spasm. Adv Neurol 1988;49:479-491.
30. Snow BJ, Tsui JKC, Bhatt MH, Varelas M, Hashimoto SA, Calne DB: Treatment of spasticity with botulinum toxin: A double-blind study. Ann Neurol 1990;28:512-515.
31. Schwartz KS, Jankovic J: Predicting the response to botulinum toxin injection for the treatment of cervical dystonia (abstract). Neurology 1990;40(suppl 1):382.
32. Ludlow CL, Hallett M, Rhew K, Cole R, Shimizu T, Sakaguchi G, et al: Therapeutic use of type F botulinum toxin. N Engl J Med 1992; 326:349-350.
33. Physicians' Desk Reference, ed 49. Montvale, Medical Economics Data, 1995, vol 15, pp 494-496.
34. Schantz EJ, Johnson EA: Dose standardisation of botulinum toxin. Lancet 1990;335:421
35. Pasricha PJ, Ravich WJ, Kalloo AN: Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in piglets. Gastroenterology 1993;105:1045-1049.
36. Pasricha PJ, Ravich WJ, Kalloo AN: Botulinum toxin for achalasia. Lancet 1993;341:244-245.
37. Pasricha PJ, Rai R, Ravich WJ, Hendrix TR: Kalloo AN: Botulinum toxin for achalasia: Long-term follow-up and predictors of out-come. Gastroenterology 1995;108:A187.
38. Annese V, Perri F, Napolitano G, Basciani M, Simorie P, Andriulli A, Vantrappen G: Botulinum toxin for achalasia: A placebo controlled trial with follow-up of six months. Gastroenterology 1995;108:A563.
39. Bansal R, Scheiman JM, Barnett JL, Nostrant TT: A randomized trial of Witzel pneumatic dilatation vs. intrasphincteric injection of botulinum toxin for achalasia. Gastroenterology 1995;108:A52.
40. Hills C, Schiano T, Parkman HP, Dabezies MA, Cohen S, Fisher RS, Miller LS: Botulinum toxin improves symptoms in idiopathic, but not secondary achalasia. Am J Gastroenterol. in press.
41. Jin HO, Potter GD, Shah AN, Ona FV, Malkin M, Chey WY: Effect of intrasphincteric injection of botulinum toxin on esophageal motility in achalasia. Gastroenterology 1995;108: A123.
42. Kotfila R, Camp R, Trudeau W: Botulinum toxin (Botox) injection in achalasia patients failing pneumatic dilation and medical therapy. Gastroenterology 1995;108:A136.
43. Schiano TD, Fisher RS, Parkman HP, Cohen S, Dabezies M, Miller LS: Use of high resolution endoscopic ultrasonography to assess esophageal wall damage after pneumatic dilatation and botulinum toxin injection to treat achalasia. Gastroenterology 1995;108:A213.
44. Waterfall WE, Tougas G, Fachnie B, Chauhan U: Clinical and manometric response to botulinum toxin (Botox) used as primary treatment for achalasia. Gastroenterology 1995;108: A255.
45. Rollan A, Gonzalez R, Carvajal S, Chianale J: Endoscopic intrasphincteric injection of botulinum toxin for the treatment of achalasia. J Clin Gastroenterol 1995;20:189-191.
46. MacKenzie I, Burnstock G, Dolly JD: The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant autonomic neuromuscular neurotransmission. Neuroscience 1982;7:997-1006.
47. Lynn RB: Mechanisms of esophageal pain. Am J Med 1992;92:5A-11S-19S.
48. Parkman HP, Ma RC, Stapelfeldt WH, Szurszewski JH: Direct and indirect mechanosensory pathways from the colon to the inferior mesenteric ganglion. Am J Physiol 1993;265: G499-G505.
49. Schroeder PL, Richter JE: Treatment of achalasia: Botulinum toxin vs pneumatic dilatation. Am J Gastroenterology 1995;90:1571.
50. Miller LS, Schiano TD, Ter R, Parkman HP, Cohen S, Fisher RS: Injection of botulinum toxin relieves symptoms in patients with diffuse esophageal spasm and nonspecific esophageal motility disorders. Gastroenterology 1995; 108:168.A.